Deepening Digitalization In Drug Discovery At PTC Therapeutics

As drug discovery programs scale, the ability to access reliable physicochemical property data directly within everyday research systems becomes critical. At PTC Therapeutics, efforts to modernize medicinal chemistry workflows centered on reducing manual data handling and enabling faster, more confident decision-making across a rapidly expanding compound library. By embedding high‑throughput property prediction into existing informatics platforms, chemists gained immediate visibility into key parameters such as pKa, logP, and logD—without leaving their core tools. This shift supported quicker trend analysis, stronger structure–property insights, and more efficient hypothesis testing across hundreds of thousands of compounds. The result is a more connected, collaborative approach to discovery, where data integrity improves and teams can focus on advancing the most promising candidates.

Learn about how deeper digital integration can remove friction from early research and accelerate progress toward better therapeutics.